Project NextGen: Innovation in Clinical Manufacturing of COVID-19 Vaccines
Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFOFFICE OF ASSISTANT SECRETARY FOR PREPAREDNESS AND RESPONSEBARDA - ASPR / DAAPPO / BARDA DCMAWASHINGTON, DC, 20515, USA

Original Source

https://sam.gov/opp/9522b1ab20324bc2bfda0ae326e77e8e/view
Timeline
    Description

    Special Notice HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking proposals for Project NextGen: Innovation in Clinical Manufacturing of COVID-19 Vaccines. This project aims to enhance the manufacturing process of COVID-19 vaccines. The solicitation is issued through the Rapid Response Partnership Vehicle (RRPV) Consortium on behalf of the Biomedical Advanced Research and Development Authority (BARDA). Interested offerors can access the full Request for Project Proposals (RPP) and information on joining the consortium through the RRPV website at www.rrpv.org. The place of performance for this project is Summerville, SC, USA.

    Point(s) of Contact
    No information provided.
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    Project NextGen: Innovation in Clinical Manufacturing of COVID-19 Vaccines
    Currently viewing
    Special Notice
    Similar Opportunities
    BARDA DRIVe EZ-BAA-22-100-SOL-00003
    Buyer not available
    Solicitation: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking proposals for BARDA DRIVe EZ-BAA-22-100-SOL-00003. This procurement is for health research and development services, health care services, and experimental development. The announcement serves as a reissuance of the BARDA DRIVe EZ-BAA and supersedes prior iterations. For more information, please visit https://drive.hhs.gov/.
    Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
    BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)
    Buyer not available
    The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is soliciting innovative research proposals under the Easy Broad Agency Announcement (EZ-BAA) BAA-22-100-SOL-00003. The initiative aims to address high-risk biomedical challenges related to emerging infectious diseases and public health emergencies, with specific Areas of Interest (AOIs) including vaccine efficacy enhancement, portable viral diagnostics, and medical countermeasures for acute radiation syndrome. This opportunity is crucial for advancing public health preparedness and fostering innovation in medical technologies. Interested parties must have active registration with SAM.gov and are encouraged to submit abstracts by various deadlines, with the next significant closing date for AOI submissions set for March 15, 2024. For further inquiries, contact Sieaun Marks at DRIVeAcquisitions@hhs.gov.
    Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
    BARDA DRIVe EZ-BAA-22-100-SOL-00003
    Buyer not available
    Solicitation: HEALTH AND HUMAN SERVICES, DEPARTMENT OF is seeking HEALTH R&D SERVICES, HEALTH CARE SERVICES, and EXPERIMENTAL DEVELOPMENT through the BARDA DRIVe EZ-BAA-22-100-SOL-00003. This procurement is a reissuance of the BARDA DRIVe EZ-BAA and supersedes prior iterations such as BAA-20-100-SOL-0002. For more information, please visit https://drive.hhs.gov/.
    PROactive Solutions for Prolonging Resilience (PROSPR)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program. This initiative aims to extend the healthspan of Americans by developing interventions that address the underlying causes of age-related health decline, including the establishment of a predictive Intrinsic Capacity score and the repurposing of FDA-approved drugs. The program emphasizes a structured, multidisciplinary approach over a five-year timeline, focusing on key milestones such as in-home assessment technologies and decentralized clinical trials to create innovative preventative care models. Interested proposers are encouraged to reach out to the PROSPR Team at PROSPR@arpa-h.gov for inquiries, and further details can be found at the ARPA-H website. The final solicitation is anticipated to be published at a later date.
    Bulk Pharmaceuticals - Group A (Materiel)
    Buyer not available
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response, is seeking proposals for the procurement of bulk pharmaceuticals under the solicitation titled "Bulk Pharmaceuticals - Group A (Materiel)." This procurement aims to acquire essential medications, including Albuterol Nebulizer Solution, Amoxicillin/Clavulanate, and Doxycycline, with a requirement that bidders submit offers for the full quantity of each product listed. The successful contractor will be responsible for ensuring a reliable supply of these pharmaceuticals, which are critical for healthcare operations and emergency preparedness. Interested vendors should direct inquiries to Terri Reed at terri.reed@hhs.gov or Kimberly Golden at kimberly.golden1@hhs.gov, with proposals due by the specified deadline outlined in the solicitation documents.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
    Buyer not available
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits
    Buyer not available
    Notice of Intent BD Rhapsody Single-Cell Analysis Reagent Kits The Department of Health and Human Services, Department of, National Institutes of Health, is planning to procure BD Rhapsody Single-Cell Analysis Reagent Kits. These kits are used for the manufacture of human cells and tissue-based products utilized in phase I/II clinical protocols for transplantation, adoptive immunotherapy, and gene therapy conducted in the Clinical Center at the NIH. The procurement includes a standing order for multi-type sequencing kits and reagents with a short shelf life. The contractor will be responsible for shipping the sufficient reagents and kits following the scheduled delivery dates. The shelf life of the sequencing reagents should be at least 3 months, and the shelf life of library generation kits should be at least 6 months. The contractor is also required to provide technical support for all kits and reagents at no additional cost. The period of performance for this procurement is from 5/1/2024 to 8/30/2024. The delivery schedule is overnight delivery Monday through Thursday to the Center for Cellular Engineering (CCE) at NIH/CC in Bethesda, MD. The vendor will be responsible for ensuring the safe transport of cryopreserved patient cells and maintaining the temperature and other parameters during the shipment of reagents and kits. The contractor will be paid per product delivered and is required to provide hard copies of proofs of each product delivered. Interested parties can submit their capabilities to the Office of Purchasing and Contracts by May 1st, 9:00 AM EST. Please note that this is not a request for proposal.